Skip to main content
Premium Trial:

Request an Annual Quote

KTH Human Protein Atlas Project to Use BioSilta's EnBase Media for Secondary Screening

Premium

This story originally ran on May 20.

Finnish biotech firm BioSilta said this week that the KTH Royal Institute of Technology Stockholm had adopted the company's newly developed EnBase Flo enzyme release media technology for use in secondary screening of poorly expressing proteins as part of the Swedish Human Protein Atlas project.

Use of EnBase Flo will increase the efficiency of the secondary screening process by allowing the KTH researchers to scale down from a shake-flask culture format to a 96-well microtiter plate format while retaining the same amount and quality of cell mass and recombinant protein production, BioSilta CEO Russell Golson told ProteoMonitor.

EnBase kits allow researchers to precisely regulate the release of nutrients to growing cultures, which, according to the company, allows for the production of up to 50 times more cells and 10 times more recombinant protein than traditional methods.

BioSilta has been working with KTH researchers since earlier this year, testing the technology for use in the Human Protein Atlas project, Golson said.

"KTH is quite a conservative group, and we had to go through more than two rounds to ensure that they were getting the quantitative and qualitative results that they were getting with their traditional methods," he said.

Golson declined to give a precise figure when asked the value of BioSilta's contract with KTH, but he characterized the contract as "significant."

"We're a small company, and this is the first customer who will be routinely using it in this type of screening environment," he said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.